Cited by 146Mitochondrial Function and PathologyCell Image Analysis TechniquesParkinson's Disease Mechanisms and Treatments

Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters.

Open access
Wiemerslage, Lyle, Lee, Daewoo·2016·Journal of Neuroscience Methods

Abstract

Background Studies of mitochondrial morphology vary in techniques. Most use one morphological parameter while others describe mitochondria qualitatively. Because mitochondria are so dynamic, a single parameter does not capture the true state of the network and may lead to erroneous conclusions. Thus, a gestalt method of analysis is warranted. New method This work describes a method combining immunofluorescence assays with computerized image analysis to measure the mitochondrial morphology within neuritic projections of a specific population of neurons. Six parameters of mitochondrial morphology were examined utilizing ImageJ to analyze colocalized signals. Results Using primary neuronal cultures from Drosophila, we tested mitochondrial morphology in neurites of dopaminergic (DA) neurons. We validate our model using mutants with known defects in mitochondrial morphology. Furthermore, we show a difference in mitochondrial morphology between cells treated as control or with a neurotoxin inducing PD (Parkinson's Disease in humans)-like pathology. We also show interactions between morphological parameters and experimental treatment. Comparison with existing methods Our method is a significant improvement of previously described methods. Six morphometric parameters are quantified, providing a gestalt analysis of mitochondrial morphology. Also it can target specific populations of mitochondria using immunofluorescence assay and image analysis. Conclusions We found that our method adequately detects differences in mitochondrial morphology between treatment groups. We conclude that some parameters may be unique to a mutation or a disease state, and the relationship between parameters is altered by experimental treatment. We suggest at least four variables should be considered when using mitochondrial structure as an experimental endpoint.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jneumeth.2016.01.008

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The parameters used for mitochondrial morphology analysis have been previously validated in the literature.

    “The utilization of these parameters has been previously validated in the literature using well-characterized mediators of mitochondrial fission and fusion.”

    From Aging promotes an increase in mitochondrial fragmentation in astrocytes (2024) · cites this paper as Wiemerslage and Lee, 2016

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 35

  1. Baens M Noels H Broeckx V Hagens S Fevery S Billiau AD Vankelecom H Marynen P 2006 The dark side of EGFP: defective polyubiquitination PLoS One 1 e54 17183684 PMC1762387
  2. Barrientos SA Martinez NW Yoo S Jara JS Zamorano S Hetz C Twiss JL Alvarez J Court FA 2011 Axonal degeneration is mediated by the mitochondrial permeability transition pore Neurobiology of Disease 31 3 966 78 PMC3245862 21248121
  3. Bereiter-Hahn J 1990 Behavior of mitochondria in the living cell International Review of Cytology 122 1 63 2246114
  4. Berman SB Pineda FJ Hardwick JM 2008 Mitochondrial fission and fusion dynamics: the long and short of it Cell Death and Differentiation 15 1147 52 18437161 PMC2614113
  5. Botella JA Bayersdorfer F Gmeiner F Schneuwly S 2011 Modelling Parkinson's disease in Drosophila NeuroMolecular Medicine 11 268 80 19855946
  6. Brand AH Perrimon N 1993 Targeted gene expression as a means of altering cell fates and generating dominant phenotypes Development 118 401 15 8223268
  7. Chang DTW Reynolds IJ 2006 Mitochondrial trafficking and morphology in healthy and injured neurons Progress in Neurobiology 80 241 68 17188795
  8. Cheng A Hou Y Mattson MP 2010 Mitochondria and neuroplasticity ASN Neuro 2 5 243 56 PMC2949087 20957078
  9. Cicchetti F Drouin-Ouellet J Gross RE 2009 Environmental toxins and Parkinson's diseases: what have we learned from pesticide-induced animal models? Trends in Pharmacological Sciences 30 9 475 83 19729209
  10. Court FA Coleman MP 2012 Mitochondria as a central sensor for axonal degenerative stimuli Trends in Neurosciences Article 2012 22578891
  11. Dagda RK Cherra SJ III Kulich SM Tandon A Park D Chu CT 2009 Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission Journal of Biological Chemistry 284 20 13843 55 19279012 PMC2679485
  12. Darya K Ganguly A Lee D 2009 Quantitative analysis of synaptic boutons in cultured Drosophila neurons Brain Research 1280 1 12 19460362
  13. Dawson TM Ko HS Dawson VL 2010 Genetic animal models of Parkinson's disease Neuron 66 646 61 20547124 PMC2917798
  14. Ghosh A Chandran K Kalivendi SV Joseph J Antholine WE Hillard CJ Kanthasamy Ar Kanthasamy An Kalyanaraman B 2010 Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model Free Radical Biology & Medicine 49 1674 1684 20828611 PMC4020411
  15. Goldman S Roy N 2000 Reply to “Human neural progenitor cells: better blue than green? Nature Medicine 6 483 4 10802678
  16. Jellenger KA 2012 Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts Movement Disorders 27 1 8 30 22081500
  17. Koopman WJH Visch HJ Smeitink JAM Willems PHGM 2006 Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts Cytometry Part A 69A 1 1 12 16342116
  18. Lê S Rennes A Josse J Husson F 2008 FactoMineR: an R package for multivariate analysis Journal of Statistical Software 1 18
  19. Leonard AP Cameron RB Speiser JL Wolf BJ Peterson YK Schnellmann RG Rohrer B 2015 Quantitative analysis of mitochondrial morphology and membrane potential in living cells using high-content imaging, machine learning, and morphological binning Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1853 2 348 360 25447550 PMC4289477
  20. Levy OA Malagelada C Greene LA 2009 Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps Apoptosis 14 478 500 19165601 PMC2754154
  21. Liang CL Wang TT Luby-Phelps K German DC 2007 Mitochondrial mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease Experimental Neurology 203 370 80 17010972
  22. Liu HS Jan MS Chou CK Chen PH Ke NJ 1999 Is Green Fluorescent Protein Toxic to the Living Cells? Biochemical and Biophysical Research Communications 260 712 7 10403831
  23. Manning-Boğ AB Langston JW 2007 Model fusion: the next phase in developing animal models for Parkinson's disease Neurotoxicity Research 11 3,4 219 40 17449461
  24. Martinou JC Youle RJ 2011 Mitochondria in Apoptosis: Bcl-2 family Members and Mitochondrial Dynamics Developmental Cell 21 1 92 101 21763611 PMC3156409
  25. Nakamura K Nemani VM Azarbal F Skibinski G Levy JM Egami K Munishkina L Zhang J Gardner B Wakabayashi J Sesaki H Cheng Y Finkbeiner S Nussbaum RL Masliah E Edwards RH 2011 Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein Journal of Biological Chemistry 286 23 20710 26 21489994 PMC3121472
  26. Okamoto K Shaw JM 2005 Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes Annual Review of Genetics 39 503 36 16285870
  27. Perier C Vila M 2012 Mitochondrial biology and Parkinson's disease Cold Spring Harbor Perspectives in Medicine 4 a009332 22355801 PMC3281591
  28. Przedborski S Jackson-Lewis V Naini AB Jakowec M Petzinger G Miller R Akam M 2001 The Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety Journal of Neurochemistry 76 1265 74 11238711
  29. Rafelski SM Marshall WF 2008 Building the cell: design principles of cellular architecture Nature Reviews Molecular Cell Biology 9 593 602 18648373
  30. Rugarli EI Langer T 2012 Mitochondrial quality control: a matter of life and death for neurons European Molecular Biology Organization Journal 31 1336 49 PMC3321185 22354038
  31. Saxena S Caroni P 2011 Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration Neuron 71 35 48 21745636
  32. Smith Y Wichmann T Factor SA DeLong MR 2012 Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa Neuropsychopharmacology 37 213 46 21956442 PMC3238085
  33. Surmeier DJ Schumacker PT 2013 Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease Journal of Biological Chemistry 288 15 10736 41 23086948 PMC3624453
  34. Wang X Su B Liu W He X Gao Y Castellani RJ Perry G Smith MA Zhu X 2011 DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phyenylpyridinium toxicity in neurons: implications for Parkinson's disease Aging Cell 10 807 23 21615675 PMC3173562
  35. Wiemerslage L Schultz BJ Ganguly A Lee D 2013 Selective degeneration of dopaminergic neurons by MPP+ and its rescue by D2 autoreceptors in Drosophila primary culture Journal of Neurochemistry 126 529 40 23452092 PMC3737274

Cited by

Sorted by citations

Authors
Wiemerslage, L., & Lee, D.
Affiliations
  • Uppsala University (SE)
  • Ohio University (US)
Corresponding author
  • Wiemerslage, Lyle
  • Lee, Daewoo
Venue
Journal of Neuroscience Methods
Publisher
Elsevier BV
Published
2016-03
Volume
262
Pages
56-65
ISSN
0165-0270 (ISSN-L)
OpenAlex
W2260239598
Cited by
146
References
0
Citations by year
2026: 8 · 2025: 8 · 2024: 12 · 2023: 23 · 2022: 24 · 2021: 16 · 2020: 15 · 2019: 13 · 2018: 13 · 2017: 8 · 2016: 6
FWCI
5.69
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience Methods (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (NS050260)
  • Korea Institute of Science and Technology
  • RIKEN Brain Science Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
mitochondrial morphology, dopaminergic neurons, neurites, Parkinson's disease, morphometric parameters, mitochondrial dynamics, Drosophila, ImageJ analysis
MeSH terms
Animals, Animals, Newborn, Cells, Cultured, Cytoskeletal Proteins, Drosophila, Embryo, Nonmammalian, Image Processing, Computer-Assisted, Membrane Proteins, Microscopy, Electron, Mitochondria, Statistics as Topic, Neurites, GTP-Binding Proteins, Principal Component Analysis, Drosophila Proteins, Animals, Genetically Modified, Green Fluorescent Proteins, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review